Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMPEST: Trientine in Hypertrophic Cardiomyopathy
NCT04706429Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Dec 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trientine in hypertrophic cardiomyopathy (HCM), sponsored by Manchester University NHS Foundation Trust. Started Dec 2020; status: completed.
02
Drugs
trientine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT04706429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04706429.